Skip to content

Bottle PEP in Cystic Fibrosis

Safety and Sustainability in Bottle PEP in Cystic Fibrosis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04961008
Enrollment
34
Registered
2021-07-14
Start date
2019-04-01
Completion date
2020-10-31
Last updated
2021-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cystic Fibrosis

Brief summary

The study aims to investigate the sustainability of Bottle-PEP in patients with cystic fibrosis

Interventions

OTHERBottle-PEP

A device that gives positive pressure from a bottle with the help of a non deflating tube

Routine pulmonary physiotherapy

Sponsors

Marmara University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosis of cystic fibrosis * Acute exacerbation

Exclusion criteria

* Any contraindication using the Bottle - PEP such as the presence of pneumothorax

Design outcomes

Primary

MeasureTime frameDescription
6 minute walk testevery 3 monthsdistance of meters walked in 6 minutes

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026